YBGJ
What one share of Yubo International Biotech Limited holds
Electromedical and Electrotherapeutic Apparatus
We are a U.S. holding company primarily operating through our wholly owned subsidiary, Platinum International Biotech Co., Ltd., a company organized under the laws of the Cayman Islands (“Platinum”).
Yubo International Biotech Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.01 |
| Cash and investments | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$0.19 | — | −$0.05 | — | −$1.16 |
| 2018 | — | −$0.12 | — | −$0.05 | — | −$1.29 |
| 2019 | — | −$0.13 | — | −$0.03 | — | −$1.41 |
| 2020 | — | −$0.11 | — | −$0.02 | — | −$1.52 |
| 2023 | — | −$0.10 | — | −$0.06 | — | −$0.15 |
| 2024 | — | −$0.01 | — | −$0.01 | — | −$0.03 |
| 2025 | $0.00 | −$0.01 | — | −$0.01 | — | −$0.01 |